CSS
PGEN icon

Cubist Systematic Strategies’s Precigen PGEN Stock Holding History

Cubist Systematic Strategies’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$321K Buy
+97,500
New +$275K ﹤0.01% 2470

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's PGEN Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Precigen (PGEN) in Q2 2023, closing a stake of 56,110 shares — an estimated $59.5K sold.

Cubist Systematic Strategies first reported a position in PGEN in Q2 2015 and held it in 21 quarters. The position peaked at $1.69M in Q3 2015. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 56,110 Precigen shares in Q2 2023, an estimated $59.5K.
  • Cubist Systematic Strategies first reported a position in Precigen in Q2 2015 and held it in 21 quarters.
  • Cubist Systematic Strategies's Precigen position peaked at $1.69M in Q3 2015.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.